Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 577 to 578 of 578 entries
Sorted by: Best Match Show Resources per page
Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections.

Transplantation direct

Stewart ZA, Stern J, Ali NM, Kalia HS, Khalil K, Jonchhe S, Weldon EP, Dieter RA, Lewis TC, Funches N, Crosby S, Seow M, Berger JC, Dagher NN, Gelb BE, Watkins AC, Moazami N, Smith DE, Kon ZN, Chang SH, Reyentovich A, Angel LF, Montgomery RA, Lonze BE.
PMID: 34514117
Transplant Direct. 2021 Sep 07;7(10):e762. doi: 10.1097/TXD.0000000000001222. eCollection 2021 Oct.

Transplanting hepatitis C viremic donor organs into hepatitis C virus (HCV)-negative recipients is becoming increasingly common; however, practices for posttransplant direct-acting antiviral (DAA) treatment vary widely. Protracted insurance authorization processes for DAA therapy often lead to treatment delays.METHODS: At...

Cite
Stewart ZA, Stern J, Ali NM, et al. Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplant Direct. 2021;7(10):e762doi: 10.1097/TXD.0000000000001222.
Stewart, Z. A., Stern, J., Ali, N. M., Kalia, H. S., Khalil, K., Jonchhe, S., Weldon, E. P., Dieter, R. A., Lewis, T. C., Funches, N., Crosby, S., Seow, M., Berger, J. C., Dagher, N. N., Gelb, B. E., Watkins, A. C., Moazami, N., Smith, D. E., Kon, Z. N., Chang, S. H., Reyentovich, A., Angel, L. F., Montgomery, R. A., & Lonze, B. E. (2021). Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplantation direct, 7(10), e762. https://doi.org/10.1097/TXD.0000000000001222
Stewart, Zoe A, et al. "Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections." Transplantation direct vol. 7,10 (2021): e762. doi: https://doi.org/10.1097/TXD.0000000000001222
Stewart ZA, Stern J, Ali NM, Kalia HS, Khalil K, Jonchhe S, Weldon EP, Dieter RA, Lewis TC, Funches N, Crosby S, Seow M, Berger JC, Dagher NN, Gelb BE, Watkins AC, Moazami N, Smith DE, Kon ZN, Chang SH, Reyentovich A, Angel LF, Montgomery RA, Lonze BE. Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplant Direct. 2021 Sep 07;7(10):e762. doi: 10.1097/TXD.0000000000001222. eCollection 2021 Oct. PMID: 34514117; PMCID: PMC8425828.
Copy Download .nbib Format: NLM
Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign.

Brinton TJ, Kurihara CQ, Camarillo DB, Pietzsch JB, Gorodsky J, Zenios SA, Doshi R, Shen C, Kumar UN, Mairal A, Watkins J, Popp RL, Wang PJ, Makower J, Krummel TM, Yock PG.
UIID-AD: 195
2013;41:1803-1810. doi: 10.1007/s10439-013-0761-2.

The Stanford Biodesign Program began in 2001 with a mission of helping to train leaders in biomedical technology innovation. A key feature of the program is a full-time postgraduate fellowship where multidisciplinary teams undergo a process of sourcing clinical...

Cite
Brinton TJ, Kurihara CQ, Camarillo DB, et al. Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign. 2013;41:1803-1810doi: 10.1007/s10439-013-0761-2.
Brinton, T. J., Kurihara, C. Q., Camarillo, D. B., Pietzsch, J. B., Gorodsky, J., Zenios, S. A., Doshi, R., Shen, C., Kumar, U. N., Mairal, A., Watkins, J., Popp, R. L., Wang, P. J., Makower, J., Krummel, T. M., & Yock, P. G. (2013). Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign. 411803-1810. https://doi.org/10.1007/s10439-013-0761-2
Brinton, T J, et al. "Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign." vol. 41 (2013): 1803-1810. doi: https://doi.org/10.1007/s10439-013-0761-2
Brinton TJ, Kurihara CQ, Camarillo DB, Pietzsch JB, Gorodsky J, Zenios SA, Doshi R, Shen C, Kumar UN, Mairal A, Watkins J, Popp RL, Wang PJ, Makower J, Krummel TM, Yock PG. Outcomes from a Postgraduate Biomedical Technology Innovation Training Program: The First 12 Years of Stanford Biodesign. 2013;41:1803-1810. doi: 10.1007/s10439-013-0761-2. UIID-AD: 195.
Copy Download .nbib Format: NLM
Showing 577 to 578 of 578 entries